GL
NYSE · USDOne year, rebased to 100
GL SPY XLF (sector ETF) · weekly closesScore DNA
Each bar is a 0-100 score within the scored universeFlags
Smart-money strip
Each disclosure source on its own window. Filings coinciding is not coordination.Key financials · FY2025
USD, fiscal year. Stock-based compensation is non-cash; shown against FCF.Valuation
GL vs industry median
60 companies in Insurance - LifeEarnings delivery
Next report 2026-10-21 · consensus EPS $4.91Peers
Market-cap band, not the industry cohort above| Company | Mkt cap | P/E | ROE | Net margin | Rev growth | 12m return |
|---|---|---|---|---|---|---|
| GL Globe Life Inc. | $13.0B | 11.1x | 20.3% | 19.6% | +3.8% | +27.3% |
| UNM Unum Group | $14.6B | 21.5x | 6.4% | 7.8% | +3.3% | +25.9% |
| JXN Jackson Financial Inc. | $8.8B | 163.2x | 1.0% | — | +18.6% | +39.2% |
| PRI Primerica, Inc. | $8.7B | 11.3x | 33.0% | 23.4% | +7.6% | +9.7% |
| VOYA Voya Financial, Inc. | $8.5B | 15.7x | 13.1% | 5.0% | −25.5% | +31.9% |
| LNC Lincoln National Corporation | $7.6B | 3.3x | 22.6% | 29.3% | +7.2% | — |
| PUK Prudential plc | $29.6B | 8.5x | 39.3% | 6.4% | +175.6% | — |
| CNO CNO Financial Group, Inc. | $5.1B | 18.4x | 10.9% | 9.8% | +6.0% | — |
Recent 8-K filings
Context
Full factsheet
The PDF carries everything on this page plus the cash-allocation waterfall, Form 144 notices, 13F holder detail, dark-pool and short-flow history, seasonality and the moat assessment (Weak).
Read it in the browser Download (PDF)All fundamentals · 140 measures in 13 categories
Percentile = where GL sits among 25 scored companies in Insurance - Life (0 = lowest value, 100 = highest). It is a position, not a grade. Balance-sheet ratios built for operating companies are n/a for lenders and insurers.Valuation
| Measure | GL | Industry percentile |
|---|---|---|
| P/E (TTM) | 10.7x | 61st |
| PEG (P/E ÷ 3-yr EPS CAGR) | 0.53 | 73rd |
| Price / sales | 2.1x | 83rd |
| Price / book | 2.1x | 88th |
| Price / tangible book | 2.5x | 83rd |
| Price / free cash flow | n/a | |
| Price / operating cash flow | n/a | |
| Enterprise value | n/a | |
| EV / sales | n/a | |
| EV / EBITDA | n/a | |
| EV / EBIT | n/a | |
| EV / free cash flow | n/a | |
| Earnings yield | 9.3% | 42nd |
| FCF yield | n/a | |
| Operating cash flow yield | n/a | |
| Graham number (per share) | $162.37 | 70th |
Profitability (TTM)
| Measure | GL | Industry percentile |
|---|---|---|
| Gross margin | n/a | |
| EBITDA margin | n/a | |
| Operating margin | 9.2% | 39th |
| EBIT margin | 10.2% | 39th |
| Net margin | 19.6% | 92nd |
| NOPAT margin | 7.5% | 38th |
| FCF margin | n/a | |
| Operating cash flow margin | n/a | |
| R&D / revenue | 0.0% | 0th |
| SG&A / revenue | 5.2% | 29th |
| Stock comp / revenue | 0.0% | 0th |
| Effective tax rate | 19.2% | 50th |
Returns on capital
| Measure | GL | Industry percentile |
|---|---|---|
| ROE (on average equity) | 20.9% | 88th |
| ROA | 4.0% | 92nd |
| ROIC | n/a | |
| ROCE | n/a | |
| Return on tangible assets | 2.1% | 79th |
| Cash ROIC (OCF / invested capital) | n/a | |
| Gross profitability (GP / assets) | n/a | |
| ROIC, 3-yr average | n/a | |
| ROIC, 5-yr average | n/a | |
| ROE, 5-yr average | 19.2% | 89th |
| Incremental ROIC | n/a |
Growth
| Measure | GL | Industry percentile |
|---|---|---|
| Revenue growth (TTM YoY) | 5.3% | 43rd |
| Revenue growth (QoQ) | 2.6% | 50th |
| Revenue CAGR, 3 yr | 7.1% | 85th |
| Revenue CAGR, 5 yr | 4.5% | 62nd |
| Gross profit CAGR, 3 yr | n/a | |
| Operating income CAGR, 3 yr | -17.8% | 24th |
| Net income growth (TTM YoY) | 13.8% | 27th |
| Net income CAGR, 3 yr | 13.0% | 72nd |
| EPS growth (TTM YoY) | 18.0% | 32nd |
| EPS CAGR, 3 yr | 20.2% | 72nd |
| EPS CAGR, 5 yr | 15.5% | 91st |
| FCF growth (TTM YoY) | n/a | |
| FCF CAGR, 3 yr | n/a | |
| Operating cash flow CAGR, 3 yr | n/a | |
| Book value CAGR, 3 yr | 23.1% | 100th |
| Dividend CAGR, 3 yr | 9.0% | 95th |
| Sustainable growth rate | 19.4% | 91st |
Margin history & stability
| Measure | GL | Industry percentile |
|---|---|---|
| Gross margin, 3-yr average | n/a | |
| Operating margin, 3-yr average | 18.2% | 57th |
| Net margin, 3-yr average | 18.7% | 91st |
| FCF margin, 3-yr average | n/a | |
| Revenue stability (0-1) | 0.90 | 83rd |
| Earnings stability (0-1) | 0.93 | 100th |
| Margin stability (0-1) | 0.75 | 74th |
Liquidity (latest quarter)
| Measure | GL | Industry percentile |
|---|---|---|
| Cash & short-term investments | n/a | |
| Net cash (− = net debt) | n/a | |
| Working capital | n/a | |
| Current ratio | n/a | |
| Quick ratio | n/a | |
| Cash ratio (cash + ST investments / current liabilities) | n/a | |
| Defensive interval (days) | n/a |
Leverage & solvency (latest quarter)
| Measure | GL | Industry percentile |
|---|---|---|
| Total debt | n/a | |
| Debt / equity | n/a | |
| Net debt / equity | n/a | |
| Debt / assets | n/a | |
| Debt / capital | n/a | |
| Debt / EBITDA | n/a | |
| Net debt / EBITDA | n/a | |
| Interest coverage (EBIT / interest) | n/a | |
| Cash interest coverage | n/a | |
| Debt payback (years of OCF) | n/a | |
| Liabilities / assets | 80.5% | 8th |
| IS credit model rating | A | |
| Implied credit spread (bps) | 150 | 21st |
Efficiency
| Measure | GL | Industry percentile |
|---|---|---|
| Asset turnover | n/a | |
| Fixed asset turnover | n/a | |
| Inventory turnover | n/a | |
| Receivables turnover | n/a | |
| Days sales outstanding | n/a | |
| Days inventory outstanding | n/a | |
| Days payables outstanding | n/a | |
| Cash conversion cycle (days) | n/a | |
| Capex / revenue | n/a | |
| Capex / depreciation | n/a | |
| Operating expense ratio | n/a |
Cash flow & earnings quality
| Measure | GL | Industry percentile |
|---|---|---|
| Operating cash flow / net income | n/a | |
| FCF / net income | n/a | |
| FCF / operating cash flow | n/a | |
| Capex / operating cash flow | n/a | |
| Accruals ratio | n/a | |
| Sloan accruals ratio | n/a | |
| Earnings quality score (0-1) | n/a |
Scores & forensic checks
| Measure | GL | Industry percentile |
|---|---|---|
| IS score | 46 | 58th |
| IS profitability | 35 | 38th |
| IS growth | 54 | 35th |
| IS value | 73 | 21st |
| IS momentum | 78 | 74th |
| IS risk (safety) | 100 | 75th |
| IS quality | 60 | 33rd |
| IS balance sheet | 41 | 0th |
| IS earnings quality | 83 | 79th |
| IS cash flow | 61 | 50th |
| Piotroski F-score (0-9) | 7 | 58th |
| Altman Z-score | — | |
| Beneish M-score | — | |
| Ohlson O-score | −6.50 | 54th |
| IS credit score | 71 | 79th |
Size (TTM)
| Measure | GL | Industry percentile |
|---|---|---|
| Market cap | $13.0B | 75th |
| Revenue | $6.2B | 29th |
| EBITDA | $631.0M | 12th |
| Net income | $1.2B | 67th |
| Free cash flow | n/a | |
| Total assets | $31.6B | 12th |
| Shareholders' equity | $6.2B | 29th |
| Employees | 3,695 | 58th |
Insider transactions, last 6 months
Form 4 · most recent 12| Date | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-22 | Hensley Robert Edward EVP & Chief Investment Officer |
Option exercise | 10,000 | $103.23 | $1.0M | 22,384 |
| 2026-09-22 | Hensley Robert Edward EVP & Chief Investment Officer |
Open-market sale | 3,344 | $169.53 | $566,912 | 19,040 |
| 2026-09-22 | Hensley Robert Edward EVP & Chief Investment Officer |
Open-market sale | 6,656 | $170.34 | $1.1M | 12,384 |
| 2026-09-22 | Hensley Robert Edward EVP & Chief Investment Officer |
Option exercise | 10,000 | $103.23 | $1.0M | 23,000 |
| 2026-08-07 | Mitchell Robert Brian EVP, General Counsel and CRO |
Option exercise | 23,000 | $103.23 | $2.4M | 30,981 |
| 2026-08-07 | Mitchell Robert Brian EVP, General Counsel and CRO |
Open-market sale | 11,454 | $182.77 | $2.1M | 19,527 |
| 2026-08-07 | Mitchell Robert Brian EVP, General Counsel and CRO |
Open-market sale | 10,529 | $183.83 | $1.9M | 8,998 |
| 2026-08-07 | Mitchell Robert Brian EVP, General Counsel and CRO |
Open-market sale | 1,017 | $184.75 | $187,892 | 7,981 |
| 2026-08-07 | Mitchell Robert Brian EVP, General Counsel and CRO |
Option exercise | 23,000 | $103.23 | $2.4M | 0 |
| 2026-07-31 | Darden James Matthew Director, Co-Chairman & CEO |
Option exercise | 50,000 | $98.32 | $4.9M | 108,451 |
| 2026-07-31 | Darden James Matthew Director, Co-Chairman & CEO |
Open-market sale | 49,600 | $182.43 | $9.0M | 58,851 |
| 2026-07-31 | Darden James Matthew Director, Co-Chairman & CEO |
Open-market sale | 400 | $183.36 | $73,343 | 58,451 |
Shares acquired vs disposed, by month
acquired disposed · all Form 4 typesBy transaction type, 6 months
| Type | Direction | Filings | Shares | Value |
|---|---|---|---|---|
| Gift | Disposed | 2 | 1,570 | — |
| Open-market sale | Disposed | 54 | 362,222 | $60.8M |
| Option exercise | Disposed | 28 | 379,589 | $39.2M |
| Option exercise | Acquired | 27 | 369,589 | $38.2M |
Form 144 notices
| Filed | Filer | Shares proposed | Est. proceeds |
|---|---|---|---|
| None on file. | |||
Congress trades
12 months: House 1 trades (1 purchases) · Senate 1 (1 purchases)| Traded | Member | Chamber | Type | Amount | Disclosed |
|---|---|---|---|---|---|
| 2026-03-27 | Alan Armstrong | Senate | Purchase | $1,001 - $15,000 | 2026-07-20 |
| 2026-01-29 | Ro Khanna | House | Purchase | $1,001 - $15,000 | 2026-02-10 |
| 2025-07-10 | Lisa McClain | House | Sale (Full) | $1,001 - $15,000 | 2025-08-13 |
| 2025-06-17 | Lisa McClain | House | Purchase | $1,001 - $15,000 | 2025-08-13 |
| 2025-06-16 | Lisa C. McClain | House | Purchase | $1,001 - $15,000 | 2025-08-13 |
| 2024-08-05 | Susan M. Collins | Senate | Sale (Full) | $15,001 - $50,000 | 2024-09-13 |
| 2024-08-05 | Susan M. Collins | Senate | Sale (Full) | $15,001 - $50,000 | 2024-09-12 |
| 2024-08-05 | Susan Margaret Collins | Senate | Sale (Full) | $15,001 - $50,000 | 2024-09-12 |
Largest 13F holders
Quarter to 2026-06-30, the latest most managers have filed| Manager | Shares | Value | % of shares out |
|---|---|---|---|
| BlackRock, Inc. | 5,528,883 | $987.9M | 7.19% |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,080,734 | $907.8M | 6.61% |
| Invesco Ltd. | 4,619,219 | $825.4M | 6.01% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4,181,598 | $747.2M | 5.44% |
| STATE STREET CORP | 3,735,409 | $667.4M | 4.86% |
| GEODE CAPITAL MANAGEMENT, LLC | 2,804,413 | $500.4M | 3.65% |
| DIMENSIONAL FUND ADVISORS LP | 2,393,372 | $427.7M | 3.11% |
| Nuveen, LLC | 1,475,438 | $263.6M | 1.92% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,440,836 | $257.4M | 1.87% |
| PZENA INVESTMENT MANAGEMENT LLC | 1,355,811 | $242.3M | 1.76% |
| Swedbank AB | 1,301,300 | $232.5M | 1.69% |
| FMR LLC | 1,266,887 | $226.4M | 1.65% |
| MORGAN STANLEY | 1,012,589 | $180.9M | 1.32% |
| NORGES BANK | 915,219 | $163.5M | 1.19% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 770,990 | $137.8M | 1.00% |
Institutional ownership by quarter
Holder changes by quarter
| Quarter | Holders | Ownership | New | Increased | Reduced | Closed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 703 | 83.7% | 107 | 237 | 215 | 62 |
| 2026-03-31 | 666 | 81.8% | 85 | 222 | 223 | 83 |
| 2025-12-31 | 680 | 83.2% | 89 | 192 | 262 | 61 |
| 2025-09-30 | 672 | 83.5% | 99 | 190 | 256 | 54 |
| 2025-06-30 | 637 | 86.5% | 96 | 204 | 224 | 53 |
| 2025-03-31 | 604 | 87.3% | 95 | 188 | 209 | 49 |
| 2024-12-31 | 566 | 88.9% | 99 | 171 | 199 | 46 |
| 2024-09-30 | 522 | 87.1% | 80 | 181 | 179 | 56 |
| 2024-06-30 | 502 | 94.3% | 73 | 160 | 197 | 160 |
| 2024-03-31 | 598 | 101.1% | 65 | 220 | 194 | 47 |
| 2023-12-31 | 584 | 96.8% | 89 | 181 | 205 | 37 |
| 2023-09-30 | 539 | 97.1% | 56 | 172 | 186 | 49 |
Schedule 13D / 13G filers
| Filed | Form | Filer | % of class | Shares |
|---|---|---|---|---|
| None on file. | ||||
ETFs with the largest holding
| ETF | Weight in fund | Holding value |
|---|---|---|
| VITSX | 0.02% | $403.1M |
| VSMPX | 0.02% | $403.1M |
| VTSAX | 0.02% | $403.1M |
| VTI | 0.02% | $403.1M |
| VOO | 0.02% | $334.4M |
| VFINX | 0.02% | $334.4M |
Share structure
Income statement
Fiscal years, USD| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $5.1B | $5.2B | $5.4B | $5.8B | $6.0B |
| Cost of revenue | $3.4B | $3.7B | $3.8B | $3.9B | $4.0B |
| Gross profit | $1.7B | $1.5B | $1.6B | $1.9B | $2.0B |
| R&D | $0 | $0 | $0 | $0 | $0 |
| SG&A | $301.9M | $335.0M | $331.9M | $382.5M | $197.7M |
| Operating income | $1.3B | $1.1B | $1.2B | $1.3B | $1.5B |
| EBITDA | $1.4B | $1.2B | $1.3B | $1.5B | $1.6B |
| Pretax income | $1.3B | $1.1B | $1.2B | $1.3B | $1.4B |
| Income tax | $243.5M | $207.7M | $223.5M | $255.9M | $278.6M |
| Net income | $1.0B | $894.4M | $970.8M | $1.1B | $1.2B |
| EPS, diluted | $7.22 | $7.47 | $10.07 | $11.94 | $14.06 |
| Diluted shares | 103.2M | 99.0M | 96.4M | 84.7M | 80.9M |
Balance sheet
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Cash & short-term investments | $21.5B | $16.7B | $103.2M | $17.4B | $18.0B |
| Receivables | $487.4M | $589.2M | $630.2M | $691.9M | $1.0B |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Total current assets | $0 | $0 | $733.4M | $0 | $19.1B |
| PP&E, net | $205.0M | $212.0M | $240.0M | $285.0M | $370.0M |
| Goodwill & intangibles | $481.8M | $481.8M | $481.8M | $490.4M | $7.5B |
| Total assets | $29.8B | $26.0B | $28.1B | $29.1B | $30.8B |
| Accounts payable | $412.9M | $509.4M | $514.9M | $532.8M | $540.8M |
| Total current liabilities | $0 | $0 | $1.5B | $0 | $2.0B |
| Long-term debt | $1.5B | $1.6B | $1.6B | $2.3B | $2.3B |
| Total liabilities | $21.1B | $22.0B | $23.6B | $23.8B | $24.8B |
| Shareholders' equity | $8.6B | $3.9B | $4.5B | $5.3B | $6.0B |
Cash flow statement
Outflows are negative| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Net income | $745.0M | $894.4M | $970.8M | $1.1B | $1.2B |
| Depreciation & amortization | $0 | $0 | $0 | $0 | $0 |
| Stock-based compensation | $0 | $0 | $0 | $0 | $0 |
| Change in working capital | $982.5M | $839.5M | $815.0M | $733.1M | $602.6M |
| Operating cash flow | $1.4B | $1.4B | $1.5B | $1.4B | $1.4B |
| Capital expenditure | −$38.2M | −$27.9M | −$49.6M | −$71.0M | −$142.5M |
| Free cash flow | $1.4B | $1.4B | $1.4B | $1.3B | $1.3B |
| Investing cash flow | −$913.4M | −$943.0M | −$926.1M | −$641.5M | −$643.6M |
| Net debt issued / repaid | $92.3M | $48.9M | $36.6M | $621.6M | −$110.7M |
| Buybacks | −$541.4M | −$454.6M | −$511.1M | −$1.0B | −$881.0M |
| Dividends paid | −$80.0M | −$80.5M | −$84.1M | −$85.5M | −$86.1M |
Ratio history
Margins on the fiscal-year (TTM at Q4) basis; multiples at each year end| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Gross margin | 25.9% | 28.9% | 31.4% | 36.5% | 33.4% |
| Operating margin | 17.8% | 20.4% | 22.9% | 23.0% | 24.4% |
| Net margin | 14.5% | 16.6% | 18.6% | 18.5% | 19.4% |
| FCF margin | 27.3% | 26.7% | 27.5% | 23.0% | 20.9% |
| ROE | 8.6% | 13.7% | 23.0% | 21.9% | 20.6% |
| ROIC | -6.9% | -8.1% | 14.9% | -11.4% | -12.5% |
| ROA | 2.5% | 3.1% | 3.6% | 3.7% | 3.9% |
| Debt / equity | 0.23 | 0.53 | 0.47 | 0.52 | 0.44 |
| Interest coverage | 11.9x | 12.8x | 12.7x | 11.4x | 11.3x |
| Current ratio | — | — | 0.49 | — | 9.66 |
| Revenue growth | +8.1% | +1.8% | +0.1% | +10.7% | +3.8% |
| EPS growth | +6.3% | +19.1% | +16.1% | +24.2% | +13.7% |
| P/E at year end | 12.3x | 13.4x | 11.8x | 8.8x | 9.7x |
| EV / EBITDA at year end | n/m | n/m | 10.4x | n/m | n/m |
| FCF yield at year end | 15.21% | 12.01% | 12.53% | 14.21% | 11.11% |
| Dividend payout | 10.7% | 9.3% | 8.7% | 8.0% | 7.4% |
Revenue by segment
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Life Segment | $2.9B | $3.0B | $3.1B | $3.3B | $3.4B |
| Health Segment | $1.2B | $1.3B | $1.3B | $1.4B | $1.5B |
| Investment Segment | $952.4M | $987.5M | — | — | — |
| Annuity Segment | $1,000 | $1,000 | $0 | — | — |
Street estimates by fiscal year
Next report 2026-10-21 · consensus EPS $4.91 · these are analysts' numbers, not ours| Fiscal year | Revenue (mean) | Revenue range | EPS (mean) | EPS range | Analysts | P/E on mean EPS |
|---|---|---|---|---|---|---|
| 2026 | $6.4B | $6.4B – $6.4B | $15.73 | $15.60 – $15.81 | 7 | 10.7x |
| 2027 | $6.8B | $6.7B – $6.9B | $16.51 | $16.03 – $16.85 | 7 | 10.2x |
| 2028 | $7.2B | $7.0B – $7.4B | $17.94 | $16.96 – $18.74 | 4 | 9.4x |
Reported vs expected, every quarter on file
| Reported | EPS expected | EPS actual | EPS surprise | Revenue expected | Revenue actual | Revenue surprise |
|---|---|---|---|---|---|---|
| 2026-07-22 | $3.67 | $3.61 | −1.6% | $1.6B | $1.6B | +0.6% |
| 2026-04-22 | $3.46 | $3.43 | −0.9% | $1.6B | $1.6B | −0.3% |
| 2026-02-04 | $3.44 | $3.39 | −1.5% | $1.5B | $1.5B | −0.8% |
| 2025-10-22 | $4.60 | $4.81 | +4.6% | $1.5B | $1.5B | −0.4% |
| 2025-07-23 | $3.25 | $3.27 | +0.6% | $1.5B | $1.5B | −1.6% |
| 2025-04-30 | $3.23 | $3.07 | −5.0% | $1.5B | $1.5B | −0.5% |
| 2025-02-05 | $3.12 | $3.14 | +0.6% | $1.5B | $1.5B | −0.7% |
| 2024-10-23 | $3.06 | $3.49 | +14.1% | $1.5B | $1.5B | −0.6% |
| 2024-07-24 | $2.91 | $2.97 | +2.1% | $1.4B | $1.4B | −0.6% |
| 2024-04-22 | $2.79 | $2.78 | −0.4% | $1.4B | $1.4B | −0.6% |
| 2024-02-07 | $2.73 | $2.80 | +2.6% | $1.4B | $1.4B | +1.2% |
| 2023-10-25 | $2.65 | $2.71 | +2.3% | $1.4B | $1.4B | −0.1% |
| 2023-07-26 | $2.57 | $2.61 | +1.6% | $1.4B | $1.3B | −3.7% |
| 2023-05-03 | $2.47 | $2.53 | +2.4% | $1.4B | $1.1B | −19.9% |
| 2023-02-01 | $2.17 | $2.24 | +3.2% | $1.3B | $1.3B | −0.8% |
| 2022-10-26 | $2.10 | $2.15 | +2.4% | $1.3B | $1.3B | −2.7% |
| 2022-07-27 | $2.05 | $2.07 | +1.0% | $1.3B | $1.3B | −2.7% |
| 2022-04-20 | $1.72 | $1.70 | −1.2% | $1.3B | $1.3B | −1.1% |
| 2022-02-02 | $1.76 | $1.70 | −3.4% | $1.3B | $1.3B | −1.0% |
| 2021-10-20 | $1.89 | $1.78 | −5.8% | $1.3B | $1.3B | +1.1% |
| 2021-07-21 | $1.82 | $1.85 | +1.6% | $1.3B | $1.3B | +0.6% |
| 2021-04-21 | $1.61 | $1.53 | −5.0% | $1.2B | $1.3B | +2.5% |
| 2021-02-02 | $1.72 | $1.74 | +1.2% | $1.2B | $1.2B | +2.3% |
| 2020-10-21 | $1.75 | $1.75 | 0.0% | $1.2B | $1.2B | 0.0% |
Off-exchange (dark pool) volume, weekly
FINRA ATS, $ billions · through the week of 2026-08-31 (FINRA publishes with a delay)| Week of | Notional | Shares | Trades |
|---|---|---|---|
| 2026-08-31 | $78.9M | 453,769 | 21,421 |
| 2026-08-24 | $111.9M | 643,426 | 22,914 |
| 2026-08-17 | $124.8M | 715,086 | 28,449 |
| 2026-08-10 | $132.8M | 729,602 | 24,918 |
| 2026-08-03 | $166.0M | 901,096 | 26,170 |
| 2026-07-27 | $204.7M | 1,145,257 | 35,612 |
Short-sale share of off-exchange volume
daily 20-day average| Date | Short share | Short volume | Total volume |
|---|---|---|---|
| 2026-10-15 | 76.7% | 105,148 | 137,148 |
| 2026-10-14 | 68.2% | 75,429 | 110,554 |
| 2026-10-13 | 60.9% | 66,434 | 109,034 |
| 2026-10-12 | 70.4% | 51,973 | 73,830 |
| 2026-10-09 | 69.4% | 73,028 | 105,172 |
| 2026-10-08 | 75.1% | 85,531 | 113,957 |
| 2026-10-07 | 55.7% | 125,934 | 225,986 |
| 2026-10-06 | 70.6% | 123,412 | 174,847 |
| 2026-10-05 | 77.9% | 86,511 | 111,091 |
| 2026-10-02 | 60.8% | 49,210 | 80,975 |
Seasonality
Average return by calendar month| Month | Avg return | Up years | Years |
|---|---|---|---|
| Jan | −0.1% | 65% | 20 |
| Feb | −1.2% | 60% | 20 |
| Mar | +1.3% | 62% | 21 |
| Apr | +1.4% | 65% | 20 |
| May | +1.7% | 50% | 20 |
| Jun | −0.8% | 55% | 20 |
| Jul | +2.4% | 65% | 20 |
| Aug | +1.0% | 60% | 20 |
| Sep | +0.6% | 50% | 20 |
| Oct | +1.4% | 60% | 20 |
| Nov | +3.0% | 85% | 20 |
| Dec | +2.8% | 75% | 20 |
Indicators
as of 2026-10-16Moving averages and bands
level (price vs level)About Globe Life Inc.
Globe Life Inc. delivers diverse life insurance and supplementary health coverage, alongside annuity products, targeting households in the lower-middle to middle-income brackets throughout the United States. The company's operations are structured into four key segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Its offerings encompass whole life, term life, and other life protection plans; supplemental health benefits like Medicare supplements, critical illness, and accident policies; and both single-premium and flexible-premium deferred annuities. Founded in 1979 and headquartered in McKinney, Texas, the enterprise rebranded from Torchmark Corporation to Globe Life Inc. in August 2019.
Key executives
| Name | Title | Pay | Born |
|---|---|---|---|
| Frank Martin Svoboda | Co-Chairman & Co-CEO | $2.7M | 1962 |
| James Matthew Darden | Co-Chairman & Co-CEO | $2.7M | 1971 |
| Thomas Peter Kalmbach | Executive Vice President & Chief Financial Officer | $1.4M | 1965 |
| Robert Brian Mitchell | Executive Vice President, General Counsel & Chief Risk Officer | $1.0M | 1964 |
| Robert E. Hensley | Executive Vice President & Chief Investment Officer | $1.0M | 1968 |
| Michael Clay Majors | Executive Vice President & Chief Strategy Officer | $952,417 | 1963 |
| Dolores L. Skarjune | Executive Vice President & Chief Administrative Officer | — | 1966 |
| Shane Henrie | Corporate Senior Vice President & Chief Accounting Officer | — | 1974 |
Executive pay, latest proxy
| Executive | Year | Salary | Stock awards | Incentive | Total |
|---|---|---|---|---|---|
| Gary L. Coleman, Co-Chairman and Chief Executive Officer | 2014 | $821,058 | $2.0M | $900,000 | $7.6M |
| Larry M. Hutchison, Co-Chairman and Chief Executive Officer | 2014 | $821,058 | $2.0M | $900,000 | $7.4M |
| Roger C. Smith President & Chief Executive Officer, American Income and Liberty | 2014 | $569,693 | $912,480 | $450,000 | $4.5M |
| Vern D. Herbel Executive Vice President & Chief Administrative Officer | 2014 | $509,923 | $570,300 | $225,000 | $3.7M |
| W. Michael Pressley Executive Vice President & Chief Investment Officer | 2014 | $459,847 | $608,320 | $225,000 | $2.8M |
| Frank M. Svoboda Executive Vice President & Chief Financial Officer | 2014 | $449,768 | $608,320 | $185,000 | $2.6M |
Employees
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| 2026-10-05 | $0.33 | 2026-10-30 |
| 2026-07-06 | $0.33 | 2026-07-31 |
| 2026-04-02 | $0.33 | 2026-05-01 |
| 2026-01-05 | $0.27 | 2026-01-30 |
| 2025-10-03 | $0.27 | 2025-10-31 |
| 2025-07-03 | $0.27 | 2025-08-01 |
| 2025-04-03 | $0.27 | 2025-05-01 |
| 2025-01-06 | $0.24 | 2025-01-31 |